Who is sponsoring NCT04807543?

NCT04807543 is sponsored by Ain Shams University.

What drugs are being tested in NCT04807543?

Interventions in NCT04807543: 17-hydroxyprogesterone caproate, Castor Oil.

What condition does NCT04807543 study?

NCT04807543 studies Preterm Premature Rupture of Membrane.

Is NCT04807543 still recruiting?

NCT04807543 is currently completed. Last updated 19 March 2021.

Last reviewed 2021-03-19 · How we verify

NCT04807543

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Progesterone on Latent Phase Prolongation in Patients With Preterm Premature Rupture of Membranes

Completed Phase 2 Last updated 19 March 2021

What this trial tests

Phase 2 trial testing 17-hydroxyprogesterone caproate in Preterm Premature Rupture of Membrane in 100 participants. Completed in 10 December 2020.

Timeline

10 January 2018

Primary endpoint
10 October 2020

10 December 2020

Quick facts

Lead sponsor	Ain Shams University
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	100
Start date	10 January 2018
Primary completion	10 October 2020
Estimated completion	10 December 2020
Sites	1 location across Egypt

Drugs / interventions tested

17-hydroxyprogesterone caproate
Castor Oil — full drug profile →

Conditions studied

Preterm Premature Rupture of Membrane — all drugs for Preterm Premature Rupture of Membrane →

Sponsor

Ain Shams University

Who can join

Adults 20 to 35, female only, with Preterm Premature Rupture of Membrane. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess the efficacy of 17-hydroxyprogesterone caproate (17P) therapy on the latency period in pregnant women with Preterm premature rupture of membranes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Preterm Premature Rupture of Membrane

Currently open trials in the same condition.

NCT06074601 — MIRACLE of LIFE Study · active not recruiting

Other Ain Shams University trials

Trials by the same sponsor.

NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04807543 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
Last refreshed: 19 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04807543.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing